Winnie Siu
Overview
Explore the profile of Winnie Siu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abrams E, Doyon-Plourde P, Davis P, Lee L, Rahal A, Brousseau N, et al.
Can Commun Dis Rep
. 2025 Jan;
51(1):26-34.
PMID: 39781233
Background: Availability of new vaccines for adults has increased interest in understanding Canada's respiratory syncytial virus (RSV) burden in older adults and adults considered at high risk of severe infection....
2.
Siu W, Killikelly A, Salvadori M, Abrams E
Can Fam Physician
. 2024 Dec;
70(11-12):e187-e191.
PMID: 39638406
No abstract available.
3.
Siu W, Killikelly A, Salvadori M, Abrams E
Can Fam Physician
. 2024 Dec;
70(11-12):697-700.
PMID: 39638376
Objective: To support family physicians in discussing respiratory syncytial virus (RSV) immunizations with patients. Sources Of Information: Information was obtained through a literature review on the burden of RSV disease...
4.
Killikelly A, Siu W, Abrams E, Salvadori M
CMAJ
. 2024 Nov;
196(39):E1326-E1327.
PMID: 39557465
No abstract available.
5.
Gil A, Siu W, Papenburg J
Can Commun Dis Rep
. 2024 Nov;
50(11):381-386.
PMID: 39525078
Background: The National Advisory Committee on Immunization (NACI) reviews the evolving evidence on influenza immunization and provides annual recommendations regarding the use of seasonal influenza vaccines. The updates the NACI...
6.
Killikelly A, Siu W, Abrams E, Salvadori M
CMAJ
. 2024 Sep;
196(29):E1011.
PMID: 39251244
No abstract available.
7.
Tuite A, Simmons A, Rudd M, Cernat A, Gebretekle G, Yeung M, et al.
CMAJ
. 2024 Sep;
196(29):E989-E1005.
PMID: 39251240
Background: Respiratory syncytial virus (RSV) vaccines could reduce disease burden and costs in older Canadian adults, but vaccination program cost-effectiveness is unknown. We evaluated the cost-effectiveness of different age cut-offs...
8.
Gebretekle G, Yeung M, Ximenes R, Cernat A, Simmons A, Killikelly A, et al.
Vaccine
. 2024 Jul;
42(21):126164.
PMID: 39079810
Background: Health Canada recently authorized the RSVpreF pregnancy vaccine and nirsevimab to protect infants against respiratory syncytial virus (RSV) disease. Objective: Assess the cost-effectiveness of RSVpreF and nirsevimab programs in...
9.
Siu W, Sinilaite A, Papenburg J
Can Commun Dis Rep
. 2024 May;
50(3-4):86-92.
PMID: 38716409
Background: Seasonal influenza infection can lead to serious complications and adverse outcomes for pregnant individuals, the developing fetus and infants younger than six months of age. This supplemental statement provides...
10.
Veroniki A, Thirugnanasampanthar S, Konstantinidis M, Dourka J, Ghassemi M, Neupane D, et al.
BMJ Evid Based Med
. 2024 Apr;
29(4):239-254.
PMID: 38604619
Objectives: To compare the efficacy of influenza vaccines of any valency for adults 60 years and older. Design And Setting: Systematic review with network meta-analysis (NMA) of randomised controlled trials...